HM
STXS icon

HealthCor Management’s Stereotaxis STXS Stock Holding History

HealthCor Management’s Portfolio STXS Stock Details STXS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-821,850
Closed -$3.07M – 73
2022
Q1 		$3.07M Buy
821,850
+165,310
+25% +$780K 0.2% 49
2021
Q4 		$4.07M Buy
+656,540
New +$3.92M 0.22% 54

Other funds holding STXS

DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
APCM
Arbiter Partners Capital Management New York $175M AUM 99.81% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
ITP
Iron Triangle Partners Cos Cob, Connecticut $875M AUM 49.85% 1-Year Est. Return
LIM
Lagoda Investment Management New York $162M AUM 49.7% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

HealthCor Management's STXS Position: Q2 2022 in Review

HealthCor Management sold out of Stereotaxis (STXS) in Q2 2022, closing a stake of 821,850 shares — an estimated $3.07M sold.

HealthCor Management first reported a position in STXS in Q4 2021 and held it in 2 quarters. The position peaked at $4.07M in Q4 2021. 85 funds tracked by Wall St. Rank hold STXS as of Q2 2022.

  • HealthCor Management reported no remaining Stereotaxis position as of Q2 2022 after selling out during the quarter.
  • HealthCor Management sold 821,850 Stereotaxis shares in Q2 2022, an estimated $3.07M.
  • HealthCor Management first reported a position in Stereotaxis in Q4 2021 and held it in 2 quarters.
  • HealthCor Management's Stereotaxis position peaked at $4.07M in Q4 2021.
  • 85 funds tracked by Wall St. Rank held Stereotaxis as of Q2 2022.

Based on HealthCor Management's 13F filing for Q2 2022, filed 15 Aug 2022.